You searched for: cefovecin (Maltesiska - Engelska)

cefovecin
cefovecin

primarjament, cefovecin jiġi
following repeated

kull kunjett fih 852 mg cefovecin
each vial contains 852 mg cefovecin.

cefovecin mic (µg/ ml) nu. ta ’
cefovecin mic (µg/ ml) no. of

340 mg cefovecin (f’forma ta’ sodju)
340 mg cefovecin (as sodium salt)

10 ml (wara rikostituzzjoni) kull kunjett fih 852 mg cefovecin
10 ml (after reconstitution) each vial contains 852 mg cefovecin.

s. aureus) juru reżistenza naturali in vitro kontra cefovecin
s. aureus) exhibited natural in vitro resistance to cefovecin

80.0 mg/ml cefovecin (f’forma ta’ sodju)
80.0 mg/ml cefovecin (as sodium salt)

primarjament, cefovecin jiġi eliminat permezz tal-kliewi f’forma mhix mibdula.
cefovecin is primarily eliminated unchanged via the kidneys.

convenia fih cefovecin, antibijotiku li jingħata bħala injezzjoni (taħt il-ġilda).
convenia contains cefovecin, an antibiotic which is given by injection (under the skin).

bħal antibijotiċi oħra, cefovecin m’huwiex effettiv kontra t-tipi ta’ batterji kollha.
like other antibiotics, cefovecin is not effective against all types of bacteria.

iżolati ta’ pseudomonas spp., enterococcus spp, and bordetella bronchiseptica huma minnhom reżistenti għall-cefovecin.
pseudomonas spp., enterococcus spp., and bordetella bronchiseptica isolates are inherently resistant to cefovecin.

il- persentaġġ ta ’ reżistenza għall- cefovecin f’ iżolati ta ’ coagulase negative staphylococci spp.
the percentage of cefovecin resistant isolates in coagulase negative staphylococci spp.

cefovecin huwa kefalosporin tat-tielet ġenerazzjoni b’attività wiesgħa kontra mikrobi gram-positive u gram-negative.
cefovecin is a third generation cephalosporin with a broad-spectrum of activity against gram-positive and gram-negative bacteria.

għandha tintuża kawtela f’pazjenti li minn qabel urew reazzjonijiet ipersensittivi għall-cefovecin, kefalosporini oħra, peniċillini, jew mediċini oħra.
caution should be exercised in patients that have previously shown hypersensitivity reactions to cefovecin, other cephalosporins, penicillins, or other drugs.

cefovecin għandu propjetajiet farmakokinetiċi uniċi b’half-lives ta’ eliminazzjoni estremament twal kemm fil-klieb kif ukoll fil-qtates.
cefovecin has unique pharmacokinetic properties with extremely long elimination half-lives in both dogs and cats.

il- persentaġġ ta’ reżistenza għall-cefovecin f’iżolati ta’ coagulase negative staphylococcus spp. (e.g.
the percentage of cefovecin resistant isolates in coagulase negative staphylococcus spp. (e.g.

cefovecin juri attività in- vitro kontra staphylococcus intermedius u pasteurella multocida li huma assoċjati ma ’ infezzjonijiet tal- ġilda tal- klieb u l- qtates.
cefovecin exhibits in vitro activity against staphylococcus intermedius and pasteurella multocida which are associated with canine and feline skin infections.